Denosumab-Induced Severe Hypocalcaemia in Chronic Kidney Disease
Background. Hypocalcaemia is increasingly recognized as a complication of denosumab use in Chronic Kidney Disease (CKD) patients with osteoporosis. Despite Therapeutic Goods Administration (TGA) notifications in 2013, we have subsequently encountered several cases of denosumab-induced hypocalcaemia,...
Saved in:
Main Authors: | Ryan Jalleh, Gopal Basu, Richard Le Leu, Shilpanjali Jesudason |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2018/7384763 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence and outcomes associated with hypocalcaemia and hypercalcaemia among pre-dialysis chronic kidney disease patients with mineral and bone disorder
by: Mei Hui Amanda Yong, et al.
Published: (2024-08-01) -
Ventricular Arrhythmia Precipitated by Severe Hypocalcaemia Secondary to Primary Hypoparathyroidism
by: S. Ashwin Reddy
Published: (2019-01-01) -
DiGeorge Syndrome Presenting as Hypocalcaemia-Induced Seizures in Adulthood
by: Adrian Zammit, et al.
Published: (2013-01-01) -
The prevalence and evidence-based management of needle fear in adults with chronic disease: A scoping review.
by: Emily Duncanson, et al.
Published: (2021-01-01) -
Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery
by: Abigail M. Schmucker, et al.
Published: (2020-01-01)